Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
  1. 4 Open-market sale SVP, Chief Accounting Officer sold 2,031 shares at an average $21.87 ($44,419)
  2. 4 Open-market sale SVP, Chief Accounting Officer sold 1,097 shares at an average $21.86 ($23,976)
  3. 4 Open-market sale Senior Vice President, R&D sold 2,062 shares at $21.50 ($44,333)
  4. 4 Open-market sale SVP, GC & Corporate Secretary sold 2,062 shares at $21.50 ($44,333)
  5. 4 Open-market sale Chief Executive Officer sold 6,442 shares at $21.50 ($138,503)
  6. 4 Open-market sale Chief Financial Officer sold 852 shares at $21.90 ($18,663)
  7. 4 Open-market sale Chief Commercial Officer sold 1,550 shares at $21.90 ($33,952)
  8. 8-K Event Results of operations
  9. 4 Open-market sale Chief Executive Officer sold 5,625 shares at $20.75 ($116,719)
  10. 4 Open-market sale Chief Medical Officer sold 2,493 shares at $20.75 ($51,730)
  11. SC 13G Stake Amended Statement of Ownership
  12. 10-Q Report Quarterly Report
  13. 8-K Event Results of operations
  14. 8-K Event Other events
  15. 4 Open-market sale Chief Commercial Officer sold 3,042 shares at $25.68 ($78,119)
  16. 4 Open-market sale SVP, Chief Accounting Officer sold 349 shares at $28.00 ($9,772)
  17. 4 Grant or award Chief Financial Officer acquired 5,000 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 8-K Event Other events
  20. S-8 Other Securities Offered to Employees in Benefit Plans

Page 24 of 65 · 1,286 filings